Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01277744
What this trial is testing

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

Who this might be right for
Advanced CancersSarcoma
M.D. Anderson Cancer Center 22
Not applicableWithdrawnNCT02778295
What this trial is testing

Biomarker for Patients With Fabry Disease (BioFabry)

Who this might be right for
AngiokeratomasChronic Kidney DiseaseOcular Abnormalities+1 more
CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Study completedNCT00661375
What this trial is testing

BAY43-9006 Phase II Study for Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03459846
What this trial is testing

Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Who this might be right for
Urinary Bladder Neoplasms
AstraZeneca 154
Not applicableStudy completedNCT03390127
What this trial is testing

Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™

Who this might be right for
Urinary Bladder NeoplasmsProstatic Neoplasms
Asan Medical Center 68
Not applicableStudy completedNCT04229862
What this trial is testing

Effect of Head Elevation on LMA Insertion

Who this might be right for
Laryngeal MasksUrinary Bladder Neoplasms
Asan Medical Center 110
Not applicableStudy completedNCT05902494
What this trial is testing

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Who this might be right for
Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer 389
Early research (Phase 1)Study completedNCT01853046
What this trial is testing

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Who this might be right for
Neoplasms
Bayer 24
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT02355886
What this trial is testing

Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy

Who this might be right for
Bladder Carcinoma
University of Washington 25
Not applicableLooking for participantsNCT06138561
What this trial is testing

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

Who this might be right for
Bladder CancerMetastatic Bladder CancerUnresectable Bladder Carcinoma+1 more
Dana-Farber Cancer Institute 180
Testing effectiveness (Phase 2)Study completedNCT02028442
What this trial is testing

Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients

Who this might be right for
Solid Tumours of Epithelial OriginMetastatic Colorectal CancerMetastatic Bladder Cancer
Akamis Bio 61
Testing effectiveness (Phase 2)Temporarily pausedNCT06860386
What this trial is testing

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 75
Testing effectiveness (Phase 2)UnknownNCT01274273
What this trial is testing

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Aarhus 118
Not applicableStudy completedNCT06761742
What this trial is testing

Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests

Who this might be right for
Renal Tumors
RenJi Hospital 1,922
Large-scale testing (Phase 3)Looking for participantsNCT07097142
What this trial is testing

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
NRG Oncology 486
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT07762586
What this trial is testing

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

Who this might be right for
Bladder Cancer
Rutgers, The State University of New Jersey 60
Next Page